BIOPORTO DIAGNOSTICS A/S
BioPorto develops diagnostic tools for early kidney injury detection.
Oversikt
- 25
- Ansatte
- Ukjent
- Omsetning
- 1995
- Grunnlagt
Nøkkelbeslutningstakere
Klaus Juhl Wulff
CFO
Gry Husby Larsen
EVP & Chief Legal Officer
Donna Haire
Board Member
Mats Thorén
Board Member
+9 flere kontakter i Funnelfeedr
Beskrivelse
BioPorto is an in vitro diagnostics company dedicated to improving patient outcomes through the development of actionable biomarkers. The company specializes in the NGAL biomarker, which is used to aid in the risk assessment and diagnosis of Acute Kidney Injury (AKI). By leveraging expertise in anti...